Page last updated: 2024-10-27

gabexate and Diabetic Glomerulosclerosis

gabexate has been researched along with Diabetic Glomerulosclerosis in 4 studies

Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.

Research Excerpts

ExcerptRelevanceReference
"To determine the role of the kallikrein-kinin (KK) system in patients with diabetes mellitus in relation to nephropathy and/or hypertension, the single-dose effects of captopril (25 mg, p."3.67The hypotensive effect of single-dose captopril in diabetics. ( Chimori, K; Kosaka, J; Miura, K; Miyazaki, S; Sakanaka, A; Yasuda, K, 1986)
"Camostat mesilate is a developed derivative of gabexate mesilate for oral administration and is known to be one of the most potent protease inhibitors."1.28Effect of camostat mesilate for the treatment of advanced diabetic nephropathy. ( Hotta, O; Ishizaki, M; Kurosawa, K; Matsubara, M; Suzuki, K; Taguma, Y, 1990)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ikeda, T1
Hoshino, T1
Matsubara, M2
Taguma, Y2
Saito, T1
Yoshinaga, K1
Kurosawa, K1
Hotta, O1
Suzuki, K1
Ishizaki, M1
Chimori, K1
Miyazaki, S1
Kosaka, J1
Sakanaka, A1
Yasuda, K1
Miura, K1

Trials

1 trial available for gabexate and Diabetic Glomerulosclerosis

ArticleYear
Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics.
    Nihon Jinzo Gakkai shi, 1992, Volume: 34, Issue:4

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Blood Coagulation; Captopril;

1992

Other Studies

3 other studies available for gabexate and Diabetic Glomerulosclerosis

ArticleYear
An inhibition of urinary albumin excretion by protease inhibitor in streptozotocin-diabetic rats.
    Nephron, 1996, Volume: 74, Issue:4

    Topics: Albuminuria; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Nephr

1996
Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.
    The Journal of laboratory and clinical medicine, 1990, Volume: 116, Issue:2

    Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Drug Therapy, Combina

1990
The hypotensive effect of single-dose captopril in diabetics.
    Clinical and experimental hypertension. Part A, Theory and practice, 1986, Volume: 8, Issue:7

    Topics: Blood Pressure; Captopril; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Drug E

1986